About NBR“Nightly Business Report produced by CNBC” (NBR) is an award-winning and highly-respected nightly business news program that airs on public television. Television’s longest-running evening business news broadcast, “NBR” features in-depth coverage and analysis of the biggest financial news stories of the day and access to some of the world’s top business leaders and policy makers.
- Ric Ocasek, The Cars' lead singer, found dead
- It's 'very difficult' for China's economy to maintain 6% growth, says Premier Li Keqiang
- Australia kept secret a China hack on its parliament to protect trade, report shows
- Trump says US 'locked and loaded' after attack on Saudi oil supply
- Dow set to lose more than 150 points on fears spiking oil will slow the global economy
NBR on TwitterMy Tweets
Subscribe to RSS
Wearable heart monitor company iRhythm is teaming up with Alphabet’s health company Verily on unspecified new technology that will monitor people at risk for atrial fibrillation, a common form of irregular heart rhythm that is associated with strokes and other serious health problems.
The first generation of wearable devices, like smartwatches and activity trackers, were aimed at helping generally healthy people track their physical activity. Now, the medical industry is looking for ways to use smart gadgets to monitor patients with chronic illnesses.
EMTs and paramedics are in demand around the country, with some 37,400 jobs set to be added through 2026, a 15 percent increase.
The health care industry experienced a number of medical breakthroughs in 2018, including for hemophilia treatment. Meg Tirrell reports.
Meg Tirrell reports on the historic costs of CAR T-cell therapy, a treatment that uses a patient’s own immune system to fight cancer.
Meg Tirrell reports on how a potentially game-changing therapy helped one little girl battle cancer.
Doctors are using new technologies to help boost organ transplant surgeries in the US that are now at a record high.
Machine learning might help computers diagnose diseases, improve and suggest treatment, and even detect illnesses before they even start.
Millions of Americans have an abnormal heart rhythm, or cardiac arrhythmia, but monitoring these cases can be cumbersome.
About 100 million Americans suffer from chronic pain. New FDA-approved tech devices that disrupt pain signals offer a solution.
A gene therapy from Spark Therapeutics is offering patients with a rare genetic retinal disease that causes blindness some hope.